Healthcare Industry News: Deferasirox
News Release - June 14, 2021
Aucta Pharma and Oakrum Pharma Announce Launch of Generic Version of JADENU(R) Sprinkle (Deferasirox Granules)PISCATAWAY, N.J., June 14, 2021 -- (Healthcare Sales & Marketing Network) -- Aucta Pharmaceuticals, Inc. (Aucta) has partnered with Oakrum Pharma, out of St. Louis, Missouri, to announce the U.S. launch of a generic version of JADENUŽ Sprinkle (Deferasirox Granules) in 90mg, 180mg, and 360mg strengths.
Deferasirox granules had annual sales in the U.S. exceeding $31 million in the aggregate for the 12-month period ending January 2021 according to available data from IQVIATM.
Shoufeng Li, CEO of Aucta Pharmaceuticals stated, "We are excited to bring another Aucta Pharmaceuticals developed product to the U.S. market through this partnership with Oakrum Pharma. Aucta Pharmaceuticals continues to expand its product portfolio in niche generics and branded specialty products and is anticipating additional approvals and launches in the next 12 months."
Marco Polizzi, CEO of Oakrum Pharma, stated, "The investments that we have made in our product development pipeline since starting this business are expected to provide significant contributions to the growth of Oakrum Pharma over the next couple of years. The launch of Deferasirox Granules is the first of several products that we expect to commercialize over the next 12-18 months. A few of these near-term launches are products developed by Aucta Pharmaceuticals."
Please see full Prescribing Information including Boxed WARNING available at www.dailymed.nlm.nih.gov.
About Aucta Pharmaceuticals, Inc.
Aucta Pharmaceuticals, Inc. is a research and technology based pharmaceutical company focusing on the development and commercialization of niche generic and branded specialty products. The company's corporate strategy is to focus on proven molecules, and, through innovation, create new therapeutics with lower scientific risk that fulfill unmet medical needs. Its specialty division has a therapeutic focus in CNS, Dermatology, and Other Specialty fields. For more information, visit www.auctapharma.com.
About Oakrum Pharma, LLC
Oakrum Pharma, LLC is a privately-owned biopharmaceutical company focusing on development and commercialization of affordable drug therapies. For more information, visit www.oakrumpharma.com.
Source: Aucta Pharma
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.